Skip to content
    Quadrille Capital logo

    Quadrille Capital

    Paris, FranceFounded 2001

    Quadrille Capital is a Paris-based private equity and venture capital firm that invests globally in high-growth technology and healthcare companies. Their strategy encompasses four complementary approaches: direct investments in growth equity companies, primary commitments to VC funds, secondary purchases in LP/GP-led transactions, and public equity investments.

    Average disclosed round size is $93.9M (across 24 rounds with reported amounts).

    Find people at Quadrille Capital on Goldilocks AI

    Portfolio

    24

    Fund Size

    $1.7B

    Top Stage

    Series B

    Last 12 Mo

    3

    Team

    AD

    Alejandra Duran Gil

    Partner

    RS

    Romain Stokes

    Co-Founder

    BD

    Brice Delome

    Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    24 investments
    CompanyRoundAmountDate
    RRecoSeries B$30MFeb 2026
    GitGuardian logoGitGuardianSeries C$50MFeb 2026
    QQidaGrowth$37MNov 2025
    Sanas logoSanasSeries B$65MFeb 2025
    EExoticcaSeries D$60MJul 2024
    Rohlik Group logoRohlik GroupSeries D$170MJun 2024
    Rohlik logoRohlikGrowth$170MJun 2024
    Hivebrite logoHivebriteSeries B$37MOct 2023
    Medwing logoMedwingSeries C$47MMar 2023
    Anyfin logoAnyfinSeries C$30MJan 2023
    Homa logoHomaSeries B$100MOct 2022
    PlanRadar logoPlanRadarSeries B$70MJan 2022
    La Belle Vie logoLa Belle VieSeries B$28.2MDec 2021
    Jobandtalent logoJobandtalentSeries E$500MDec 2021
    Anyfin logoAnyfinUnknown$44.8MOct 2021
    Rohlik logoRohlikSeries C$119MJun 2021
    Rohlik Group logoRohlik GroupGrowth$190MMar 2021
    Hinge Health logoHinge HealthSeries C$90MFeb 2020
    Intrinsic Therapeutics, Inc. logoIntrinsic Therapeutics, Inc.Growth$52MApr 2019
    ezCater logoezCaterSeries D$150MApr 2019
    IiAdvizeUnknown$37.6MOct 2017
    Intrinsic Therapeutics, Inc. logoIntrinsic Therapeutics, Inc.Series B$49MMay 2017
    Blue Jeans Network logoBlue Jeans NetworkSeries E$76.5MSep 2015
    TTamara Mellon BrandSeries C$50M

    Top Co-Investors

    Northzone4 shared
    Accel3 shared
    European Bank for Reconstruction and Development2 shared
    Sofina2 shared
    Bpifrance2 shared
    Partech2 shared
    EQT Ventures2 shared
    Augmentum Fintech2 shared
    Delos Capital2 shared
    Atomico2 shared
    Headline2 shared
    Kibo2 shared
    Eurazeo2 shared
    Left Lane Capital1 shared

    Last updated: 16 April 2026